SecBot SecBot
SECBOTREPLAY Home › Report › IOVA

IOVA · Iovance Biotherapeutics granted inducement stock options covering…

Iovance Biotherapeutics, Inc. · PRESS-RELEASE filed Jun 19, 2026 at 17:15 ET

At the news

NEUTRALIMPACT 2/10

PRESS-RELEASE filed Jun 19, 2026 at 17:15 ET

Iovance Biotherapeutics granted inducement stock options covering 140,860 shares to 27 new non-executive employees under its 2021 Inducement Plan, with an exercise price of $3.91 per share and a three-year vesting schedule. This is a routine equity grant to attract new hires and has no material impact on the company's financials or operations.

  • Granted inducement stock options for 140,860 shares to 27 new non-executive employees.
  • Exercise price set at $3.91, the closing price on June 18, 2026.
  • Options vest over three years: one-third on first anniversary, remainder in quarterly installments.
  • Granted under Iovance's Amended and Restated 2021 Inducement Plan per Nasdaq Listing Rule 5635(c)(4).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access